Harvard Pop Center Spiegelman Fellow Germana Leyna, MD, has co-authored an article published in BioMed Central that examines virologic and immunologic responses, drug resistance and mortality at 24 months postpartum in women in Tanzania who started antiretroviral therapy (ART) for life late in pregnancy. While virologic and immunologic failure was significantly higher among women who reported non-perfect adherence to ART at month 24, the mortality rate was fairly low.